AAAAAA

   
Results: 1-17 |
Results: 17
Cell-specific proteins regulate viral RNA translation and virus-induced disease
Authors: Pilipenko, EV Viktorova, EG Guest, ST Agol, VI Roos, RP
Citation: Ev. Pilipenko et al., Cell-specific proteins regulate viral RNA translation and virus-induced disease, EMBO J, 20(23), 2001, pp. 6899-6908
Controlling new prion diseases.
Authors: Roos, RP
Citation: Rp. Roos, Controlling new prion diseases., N ENG J MED, 344(20), 2001, pp. 1548-1551
The prion diseases
Authors: Mastrianni, JA Roos, RP
Citation: Ja. Mastrianni et Rp. Roos, The prion diseases, SEM NEUROL, 20(3), 2000, pp. 337-352
Adenoviral gene transfer of nitric oxide synthase increases cerebral bloodflow in rats
Authors: Luders, JC Weihl, CC Lin, G Ghadge, G Stoodley, M Roos, RP Macdonald, RL
Citation: Jc. Luders et al., Adenoviral gene transfer of nitric oxide synthase increases cerebral bloodflow in rats, NEUROSURGER, 47(5), 2000, pp. 1206-1214
Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage
Authors: Stoodley, M Weihl, CC Zhang, ZD Lin, G Johns, LM Kowalczuk, A Ghadge, G Roos, RP Macdonald, RL
Citation: M. Stoodley et al., Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage, NEUROSURGER, 46(5), 2000, pp. 1193-1202
What happens when mutant neuroserpins get into bad shape
Authors: Miller, RJ Roos, RP
Citation: Rj. Miller et Rp. Roos, What happens when mutant neuroserpins get into bad shape, LANCET, 355(9204), 2000, pp. 590-591
The CD4-mediated immune response is critical in determining the outcome ofinfection using Theiler's viruses with VP1 capsid protein point mutations
Authors: Rodriguez, M Roos, RP McGavern, D Zoecklein, L Pavelko, K Sang, HR Lin, XQ
Citation: M. Rodriguez et al., The CD4-mediated immune response is critical in determining the outcome ofinfection using Theiler's viruses with VP1 capsid protein point mutations, VIROLOGY, 275(1), 2000, pp. 9-19
Novel mutations in spastin gene and absence of correlation with age at onset of symptoms
Authors: Hentati, A Deng, HX Zhai, H Chen, W Yang, Y Hung, WY Azim, AC Bohlega, S Tandan, R Warner, C Laing, NG Cambi, F Mitsumoto, H Roos, RP Boustany, RM Ben Hamida, M Hentati, F Siddique, T
Citation: A. Hentati et al., Novel mutations in spastin gene and absence of correlation with age at onset of symptoms, NEUROLOGY, 55(9), 2000, pp. 1388-1390
The role of beta-catenin stability in mutant PS1-associated apoptosis
Authors: Weihl, CC Miller, RJ Roos, RP
Citation: Cc. Weihl et al., The role of beta-catenin stability in mutant PS1-associated apoptosis, NEUROREPORT, 10(12), 1999, pp. 2527-2532
Creutzfeldt-Jakob disease, new variant Creutzfeldt-Jakob disease, and bovine spongiform encephalopathy
Authors: Weihl, CC Roos, RP
Citation: Cc. Weihl et Rp. Roos, Creutzfeldt-Jakob disease, new variant Creutzfeldt-Jakob disease, and bovine spongiform encephalopathy, NEUROL CLIN, 17(4), 1999, pp. 835
A protein critical for immune-mediated demyelinating disease (vol 44, pg 490, 1998)
Authors: Yamasaki, K Ghadge, GD Roos, RP
Citation: K. Yamasaki et al., A protein critical for immune-mediated demyelinating disease (vol 44, pg 490, 1998), ANN NEUROL, 45(2), 1999, pp. 269-269
Mutant presenilin-1 induces apoptosis and downregulates Akt PKB
Authors: Weihl, CC Ghadge, GD Kennedy, SG Hay, N Miller, RJ Roos, RP
Citation: Cc. Weihl et al., Mutant presenilin-1 induces apoptosis and downregulates Akt PKB, J NEUROSC, 19(13), 1999, pp. 5360-5369
A controlled trial of recombinant methionyl human BDNF in ALS
Authors: Kasarskis, EJ Shefner, JM Miller, R Smith, RA Licht, J Mitsumoto, H Hopkins, LC Rosenfeld, J Pascuzzi, R Cornblath, DR Armon, C Strong, MJ Kula, R Windebank, A Bosch, EP Smith, BE Cashman, N Sivak, M Sergay, S Siddique, T Sufit, RL Johnston, W Brooke, MB Graves, MC Olney, RK Roos, RP Neville, H Ringel, SP Ross, M Bradley, WG Sharma, KR Parry, G Mandler, R Giuliani, M Thornton, CA Jackson, C Bryan, W Bromberg, M Tandan, R Fries, T Phillips, L Brooks, BR Fenichel, G Pestronk, A Bear, M Beatey, R Fuller, C Hill, R Malta, E Nakanishi, A Patel, A Thurmond, B Cedarbaum, JM Stambler, N
Citation: Ej. Kasarskis et al., A controlled trial of recombinant methionyl human BDNF in ALS, NEUROLOGY, 52(7), 1999, pp. 1427-1433
The role of immunophilins in mutant superoxide dismutase-1-linked familialamyotrophic lateral sclerosis
Authors: Lee, JP Palfrey, HC Bindokas, VP Ghadge, GD Ma, L Miller, RJ Roos, RP
Citation: Jp. Lee et al., The role of immunophilins in mutant superoxide dismutase-1-linked familialamyotrophic lateral sclerosis, P NAS US, 96(6), 1999, pp. 3251-3256
Alternative translation initiation of Theiler's murine encephalomyelitis virus
Authors: Yamasaki, K Weihl, CC Roos, RP
Citation: K. Yamasaki et al., Alternative translation initiation of Theiler's murine encephalomyelitis virus, J VIROLOGY, 73(10), 1999, pp. 8519-8526
Processing of wild-type and mutant familial Alzheimer's disease-associatedpresenilin-1 in cultured neurons
Authors: Weihl, CC Ghadge, GD Miller, RJ Roos, RP
Citation: Cc. Weihl et al., Processing of wild-type and mutant familial Alzheimer's disease-associatedpresenilin-1 in cultured neurons, J NEUROCHEM, 73(1), 1999, pp. 31-40
A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity
Authors: Lin, XQ Roos, RP Pease, LR Wettstein, P Rodriguez, M
Citation: Xq. Lin et al., A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity, J IMMUNOL, 162(1), 1999, pp. 17-24
Risultati: 1-17 |